ketanserin has been researched along with Cognitive Dysfunction in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q | 1 |
| Chen, Y | 2 |
| Xing, S | 1 |
| Liao, Q | 1 |
| Xiong, B | 1 |
| Wang, Y | 1 |
| Lu, W | 1 |
| He, S | 1 |
| Feng, F | 1 |
| Liu, W | 1 |
| Sun, H | 1 |
1 other study available for ketanserin and Cognitive Dysfunction
| Article | Year |
|---|---|
Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection.
Topics: Amyloid beta-Peptides; Animals; Binding Sites; Butyrylcholinesterase; Cell Survival; Cholinesterase | 2021 |